Dexamethasone reduces methotrexate biliary elimination and potentiates its hepatotoxicity in rats

Toxicology
Leos FuksaStanislav Micuda

Abstract

Increased hepatotoxicity of methotrexate has been reported during dexamethasone therapy in humans. Despite the observed inducing effect of dexamethasone on some methotrexate transporting proteins in the liver, the kinetic aspects of this interaction have not been studied yet. Thus, the aim of the present study was to evaluate the influence of dexamethasone on the hepatic and overall pharmacokinetics of methotrexate. Pharmacokinetics of methotrexate was evaluated in rats during an in vivo steady-state clearance study after either single intravenous dose of dexamethasone or its four-day oral administration in a dose optimized for transport proteins induction. Dexamethasone oral pretreatment reduced biliary clearance of methotrexate by 53%. Although liver tissue concentration of methotrexate increased only slightly in these animals, a significant increase in liver weights produced by dexamethasone pretreatment revealed a marked increase in liver content of the drug. An evaluation of plasma liver enzyme activities measured before and after methotrexate administration demonstrated a potentiation of corticosteroid hepatotoxicity by the cytostatic. Analysis of methotrexate transporter expression in the liver showed up-regulation of Mr...Continue Reading

References

Jan 1, 1979·Medical and Pediatric Oncology·C PerezJ Herson
Apr 29, 1978·British Medical Journal·G W AherneW F White
Jan 1, 1986·Journal of Pediatric Gastroenterology and Nutrition·T C IancuL Dembo
Nov 3, 1983·The New England Journal of Medicine·J JolivetB A Chabner
Jan 1, 1984·European Journal of Clinical Pharmacology·J Hendel, H Brodthagen
Dec 1, 1994·Clinical Pharmacokinetics·J R Brouwers, P A de Smet
Jan 27, 1998·The Journal of Biological Chemistry·K ItoY Sugiyama
Jul 15, 1998·British Journal of Clinical Pharmacology·H L McLeod
Feb 3, 1999·FEBS Letters·M DemeuleR Béliveau
Jul 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T KamisakoD Keppler
Feb 20, 2002·Journal of Gastroenterology and Hepatology·G LangmanG Todd
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Michio TakedaHitoshi Endou
Jan 23, 2003·Clinical Pharmacokinetics·Jirí GrimJirina Martínková
Jan 7, 2005·Clinical Pharmacokinetics·David CzockUlla Häussler
Mar 1, 2005·Basic & Clinical Pharmacology & Toxicology·Jaroslav ChladekJaroslava Vaneckova
Mar 1, 2005·Basic & Clinical Pharmacology & Toxicology·Stanislav MicudaJirina Martinkova
Apr 19, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jonathan M MaherCurtis D Klaassen
May 24, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Priyamvada ChandraKim L R Brouwer
Apr 6, 2006·Pflügers Archiv : European journal of physiology·Piet BorstKoen van de Wetering
May 17, 2006·The Journal of Pharmacology and Experimental Therapeutics·Ilaria BadagnaniKathleen M Giacomini
Dec 22, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S AltintasJ B Vermorken
Feb 28, 2007·Clinical and Experimental Pharmacology & Physiology·Stanislav MicudaJirina Martinkova
Aug 9, 2007·Journal of Gastroenterology and Hepatology·Stanislav MicudaJirina Martinkova
Jun 13, 2008·Biopharmaceutics & Drug Disposition·Leos FuksaStanislav Micuda
Feb 6, 2009·Journal of Pediatric Hematology/oncology·Jaroslav SterbaViera Bajciova
Apr 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria L H VlamingAlfred H Schinkel

❮ Previous
Next ❯

Citations

Jan 19, 2012·Expert Opinion on Drug Delivery·Zulfequar Ahamad KhanBrahmeshwar Mishra
Nov 19, 2011·Journal of Applied Toxicology : JAT·Benjamin R Green, Lisa J Bain
Jun 6, 2013·Advances in Pharmacological Sciences·Marinella PatanèEmilio Russo
Dec 26, 2018·Expert Opinion on Drug Metabolism & Toxicology·Dubravka VejnovićBiljana Jekić
Feb 24, 2018·Current Medicinal Chemistry·Carolina I Ghanem, Jose E Manautou
Feb 6, 2020·Biopharmaceutics & Drug Disposition·Zheng-Yuan ShiDan Yan
Feb 14, 2020·Rheumatology International·Stephan PflugbeilAstrid Ortner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Jolana CermanovaStanislav Micuda
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
J KartenbeckD Keppler
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
C C PaulusmaR P Oude Elferink
© 2022 Meta ULC. All rights reserved